Epidemiology of Brain Metastases

被引:1100
作者
Nayak, Lakshmi [1 ]
Lee, Eudocia Quant [1 ]
Wen, Patrick Y. [1 ]
机构
[1] Brigham & Womens Hosp, Dana Farber Brigham & Womens Canc Ctr, Ctr Neurooncol, Dept Neurol,Div Neurooncol, Boston, MA 02215 USA
关键词
Brain metastases; Intracranial; Incidence; Epidemiology; Non-small cell lung cancer; Breast cancer; Melanoma; CENTRAL-NERVOUS-SYSTEM; CELL LUNG-CANCER; PROPHYLACTIC CRANIAL IRRADIATION; BREAST-CANCER; CEREBRAL METASTASES; PROGNOSTIC-FACTORS; ADJUVANT CHEMOTHERAPY; MALIGNANT-MELANOMA; SURGICAL-TREATMENT; CNS METASTASES;
D O I
10.1007/s11912-011-0203-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Brain metastases are one of the most common neurologic complications of cancer. The incidence is 9%-17% based on various studies, although the exact incidence is thought to be higher. The incidence is increasing with the availability of improved imaging techniques which aid early diagnosis, and effective systemic treatment regimens which prolong life, thus allowing cancer to disseminate to the brain. Lung cancer, breast cancer, and melanoma are the most frequent to develop brain metastases, and account for 67%-80% of all cancers. Most patients with brain metastases have synchronous extracerebral metastases. Some patients present with no known primary cancer diagnosis. In children, brain metastases are rare; germ cell tumors, sarcomas, and neuroblastoma are the common offenders.
引用
收藏
页码:48 / 54
页数:7
相关论文
共 73 条
[1]
Spectrum of breast cancer metastasis in BRCA1 mutation carriers:: highly increased incidence of brain metastases [J].
Albiges, L ;
André, F ;
Balleyguier, C ;
Gomez-Abuin, G ;
Chompret, A ;
Delaloge, S .
ANNALS OF ONCOLOGY, 2005, 16 (11) :1846-U3
[2]
The Prognostic Contribution of Clinical Breast Cancer Subtype, Age, and Race Among Patients With Breast Cancer Brain Metastases [J].
Anders, Carey K. ;
Deal, Allison M. ;
Miller, C. Ryan ;
Khorram, Carmen ;
Meng, Hong ;
Burrows, Emily ;
Livasy, Chad ;
Fritchie, Karen ;
Ewend, Matthew G. ;
Perou, Charles M. ;
Carey, Lisa A. .
CANCER, 2011, 117 (08) :1602-1611
[3]
Craniotomy for the resection of metastatic brain tumors in the US, 1988-2000 - Decreasing mortality and the effect of provider caseload [J].
Barker, FG .
CANCER, 2004, 100 (05) :999-1007
[4]
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system [J].
Barnholtz-Sloan, JS ;
Sloan, AE ;
Davis, FG ;
Vigneau, FD ;
Lai, P ;
Sawaya, RE .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :2865-2872
[5]
Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma [J].
Bendell, JC ;
Domchek, SM ;
Burstein, HJ ;
Harris, L ;
Younger, J ;
Kuter, I ;
Bunnell, C ;
Rue, M ;
Gelman, R ;
Winer, E .
CANCER, 2003, 97 (12) :2972-2977
[6]
Bouffet E, 1997, CANCER-AM CANCER SOC, V79, P403, DOI 10.1002/(SICI)1097-0142(19970115)79:2<403::AID-CNCR25>3.0.CO
[7]
2-3
[8]
Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer:: the dark side of the moon?: A meta-analysis of the randomized trials [J].
Bria, Emilio ;
Cuppone, Federica ;
Fornier, Monica ;
Nistico, Cecilia ;
Carlini, Paolo ;
Milella, Michele ;
Sperduti, Isabella ;
Terzoli, Edmondo ;
Cognetti, Francesco ;
Giannarelli, Diana .
BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (02) :231-239
[9]
Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer - Clinical implications for the subsequent management of the brain [J].
Chen, Allen M. ;
Jahan, Thierry M. ;
Jablons, David M. ;
Garcia, Joaquin ;
Larson, David A. .
CANCER, 2007, 109 (08) :1668-1675
[10]
Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer [J].
Clayton, AJ ;
Danson, S ;
Jolly, S ;
Ryder, WDJ ;
Burt, PA ;
Stewart, AL ;
Wilkinson, PM ;
Welch, RS ;
Magee, B ;
Wilson, G ;
Howell, A ;
Wardley, AM .
BRITISH JOURNAL OF CANCER, 2004, 91 (04) :639-643